You may also like
Prognosis when Using Extracorporeal Membrane Oxygenation (ECMO) for Critically Ill COVID-19 Patients in China: a Retrospective Case Series
As anticipated, COVID-19 is a pandemic; all healthcare resources are stretched so that ECMO is not a therapy to be rushed to the frontline. Therefore, interim treatment guidelines of recommending ECMO for critically ill COVID-19 patients should be taken cautiously.
1 min read
Blood Warm Reperfusion: A Necessary Adjunct to Heart-Valve Surgery in Low-Risk Patients?
The aim of this prospective, randomized study was to determine whether blood warm reperfusion improves myocardial protection provided by cold crystalloid cardioplegia in patients undergoing first-time elective heart-valve surgery, using cardiac troponin I release as the criterion for evaluating the adequacy of myocardial protection.
1 min read
Extracorporeal Membrane Oxygenation 2016: An Update
This review examines novel applications and recent trends in the use of ECMO over the last 2 years. These include ECMO to facilitate the safe use of other treatments, changing the timing of initiation, newer equipment and better biocompatibility, and the ability of ECMO programs to essentially choose which cluster of potential complications they are prepared to accept. ECMO continues to evolve, diversify in its applications, and improve in safety.
1 min read